TD Asset Management
ALNY icon

TD Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$144M Sell
441,177
-45,407
-9% -$14.8M 0.12% 150
2025
Q1
$131M Sell
486,584
-17,454
-3% -$4.71M 0.12% 156
2024
Q4
$119M Buy
504,038
+15,755
+3% +$3.71M 0.1% 175
2024
Q3
$134M Sell
488,283
-1,657
-0.3% -$456K 0.12% 167
2024
Q2
$119M Buy
489,940
+27,592
+6% +$6.7M 0.11% 169
2024
Q1
$69.1M Sell
462,348
-3,737
-0.8% -$558K 0.06% 254
2023
Q4
$89.2M Sell
466,085
-29,279
-6% -$5.6M 0.09% 202
2023
Q3
$87.7M Buy
495,364
+136,283
+38% +$24.1M 0.11% 157
2023
Q2
$68.2M Sell
359,081
-783
-0.2% -$149K 0.08% 203
2023
Q1
$72.1M Sell
359,864
-32,586
-8% -$6.53M 0.09% 183
2022
Q4
$93.3M Buy
392,450
+7,639
+2% +$1.82M 0.12% 150
2022
Q3
$80.6M Sell
384,811
-15,457
-4% -$3.24M 0.1% 161
2022
Q2
$58.4M Buy
400,268
+7,586
+2% +$1.11M 0.07% 227
2022
Q1
$64.1M Sell
392,682
-3,791
-1% -$619K 0.06% 246
2021
Q4
$67.2M Buy
396,473
+161,789
+69% +$27.4M 0.06% 256
2021
Q3
$44.3M Buy
234,684
+10,584
+5% +$2M 0.05% 304
2021
Q2
$40.1M Buy
224,100
+32,078
+17% +$5.74M 0.04% 338
2021
Q1
$27.1M Buy
192,022
+16,495
+9% +$2.33M 0.03% 399
2020
Q4
$22.8M Buy
175,527
+8,080
+5% +$1.05M 0.03% 416
2020
Q3
$24.4M Buy
167,447
+9,887
+6% +$1.44M 0.03% 349
2020
Q2
$23.3M Buy
157,560
+8,743
+6% +$1.29M 0.03% 331
2020
Q1
$16.2M Buy
148,817
+16,600
+13% +$1.81M 0.03% 364
2019
Q4
$15.2M Buy
132,217
+18,165
+16% +$2.09M 0.02% 444
2019
Q3
$9.17M Buy
114,052
+17,800
+18% +$1.43M 0.01% 544
2019
Q2
$6.98M Buy
96,252
+3,730
+4% +$271K 0.01% 610
2019
Q1
$8.65M Sell
92,522
-1,185
-1% -$111K 0.01% 557
2018
Q4
$6.83M Sell
93,707
-13,331
-12% -$972K 0.01% 579
2018
Q3
$9.37M Sell
107,038
-19,250
-15% -$1.68M 0.01% 551
2018
Q2
$12.4M Sell
126,288
-42,608
-25% -$4.2M 0.02% 476
2018
Q1
$20.1M Buy
168,896
+9,950
+6% +$1.19M 0.03% 378
2017
Q4
$20.2M Buy
158,946
+20,151
+15% +$2.56M 0.03% 388
2017
Q3
$16.3M Buy
138,795
+8,877
+7% +$1.04M 0.02% 432
2017
Q2
$10.4M Buy
129,918
+34,918
+37% +$2.78M 0.02% 514
2017
Q1
$4.87M Buy
95,000
+2,200
+2% +$113K 0.01% 695
2016
Q4
$3.47M Buy
92,800
+3,262
+4% +$122K 0.01% 754
2016
Q3
$6.07M Buy
89,538
+258
+0.3% +$17.5K 0.01% 653
2016
Q2
$4.95M Buy
89,280
+65,680
+278% +$3.64M 0.01% 679
2016
Q1
$1.48M Buy
23,600
+2,300
+11% +$144K ﹤0.01% 887
2015
Q4
$2.01M Buy
21,300
+2,200
+12% +$207K ﹤0.01% 833
2015
Q3
$1.54M Buy
19,100
+1,000
+6% +$80.4K ﹤0.01% 858
2015
Q2
$2.17M Buy
18,100
+3,100
+21% +$372K ﹤0.01% 844
2015
Q1
$1.57M Hold
15,000
﹤0.01% 866
2014
Q4
$1.46M Sell
15,000
-28,100
-65% -$2.73M ﹤0.01% 879
2014
Q3
$3.37M Buy
43,100
+300
+0.7% +$23.4K 0.01% 731
2014
Q2
$2.7M Sell
42,800
-12,800
-23% -$809K ﹤0.01% 785
2014
Q1
$3.73M Sell
55,600
-5,400
-9% -$363K 0.01% 722
2013
Q4
$3.92M Sell
61,000
-9,700
-14% -$624K 0.01% 700
2013
Q3
$4.53M Buy
70,700
+25,700
+57% +$1.65M 0.01% 632
2013
Q2
$1.4M Buy
+45,000
New +$1.4M ﹤0.01% 809